Personalised mobile health coaching significantly reduces diabetes risk in pregnant women and new mothers
‘Bump2Baby and Me’ app offers a potentially scalable mHealth solution in maternal healthcare
A continuous, personalised mobile health (mHealth) coaching programme can significantly reduce gestational diabetes incidence among high-risk pregnant women, independent of changes to maternal weight – according to an international study published today in the Lancet Digital Health.
Led by Professor Sharleen O’Reilly from University College Dublin, the ‘Bump2Baby and Me’ study evaluated the efficacy of a smartphone-delivered intervention from early pregnancy through 12 months postpartum. The multicentre randomised controlled trial (RCT), spanning Ireland, the UK, Spain, and Australia, is the first of its scale to provide a digital health intervention continuously through both pregnancy and an extended postpartum period.
The risk for developing gestational diabetes is strongly linked to obesity or overweight. ‘Lifestyle’ interventions typically focus on improving diet, physical activity and weight management. Our study followed two groups who received routine care only or routine care plus personalised mHealth coaching through the Bump2Baby and Me app.
The study found no difference in average maternal body mass index (BMI) at 12 months postpartum between the two groups but they did find a clinically important reduction in the number of women who developed gestational diabetes for the intervention group. These findings have potential clinical implications – showing that gestational diabetes prevention and improvements in metabolic health can be achieved without corresponding weight change. Additionally, the study noted that regular self-weighing using simple, Bluetooth-enabled digital scales was independently associated with a significant reduction in body mass index (BMI)*.
Project Lead, Prof Sharleen O’Reilly said:
“The Bump2Baby and Me trial showed that continuous, high-quality engagement with mHealth coaching can improve metabolic outcomes and reduce gestational diabetes incidence, independently of weight change.
“By utilising mHealth technology, we can deliver support in real-time directly to women when and where they need it most. Our research provides a robust, scalable framework to alleviate pressure on routine maternity services while extending preventive care beyond the hospital walls into the vital first year postpartum.”
The trial enrolled 865 pregnant women between 12 and 24 weeks’ gestation who were identified as being at increased gestational diabetes risk. Participants all received a Bluetooth-enabled scales and were randomised to either receive usual care or join the mHealth coaching programme, which used a smartphone application to provide tailored health coach support for nutrition, physical activity, and well-being. The coaches, who were trained healthcare professionals, provided live and text or video support sessions to women.
Importantly, the intervention was found to be safe, with no adverse events related to the mHealth coaching programme, while the diversity across four different healthcare systems enhances the findings generalisability to different populations.
Bridging the gap between clinical trial success and healthcare implementation remains important. To achieve this, the UCD team, along with some of the other partners, have already launched a successor initiative, Bump2Baby and Me+. Supported by €2 million in partnership funding under Horizon Europe, this initiative will focus heavily on implementation science, determining how to embed this evidence-based mHealth coaching programme into routine maternity services in diverse healthcare settings.
Ends
Media Contacts
• Lead Researcher: Professor Sharleen O’Reilly, UCD School of Agriculture and Food Science, University College Dublin; sharleen.oreilly@ucd.ie
• UCD Media Relations: Caroline Byrne, Communications Manager, UCD Research and Innovation, caroline.byrne1@ucd.ie
Notes to Editors
*Globally, women gain approx. 700g per year, which is why about half the world’s women are in either the overweight or obese categories for BMI. When women get pregnant, they need to gain weight to grow their baby but gaining more than necessary makes it harder for a woman to return to their pre-pregnancy weight (which is the optimum outcome for better health). Women with overweight or obesity tend to gain more weight during pregnancy and this adds to the challenge of getting back to pre-pregnancy weight.
The study found that women who regularly used their weighing scales to get feedback on their weight were significantly lighter than those who did not, which indicated that supplying the digital scales helped women who needed support to keep an eye on their weight. This provision helped women regardless of study group allocation as both groups got the scales. Essentially, the bluetooth scales gave useful feedback to mothers who wanted to manage their weight at home. Consequently, the team is looking at further integration of the weighing scales in the app for the Bump2Baby and Me+ study.
Further Reading
Paper: O’Reilly S, McAuliffe F, Teede H et al. Personalised mobile health coaching from early pregnancy to 12-months postpartum for females at risk of gestational diabetes (Bump2Baby and Me): a multicentre, randomised controlled trial. The Lancet Digital Health, 2026; 0.
Policy Brief #2: Addressing Gestational Diabetes Risk